Beta-Blockers: Evidence of Mortality Benefit in Ovarian Cancer (CME/CE)
(MedPage Today) -- Survival more than doubled in patients receiving agents like propranolol
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Beta-Blockers | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Heart | Inderal | Ovarian Cancer | Ovaries